Magazine Article | May 3, 2021

CEO Q&A: Dr. Aoife Brennan

Source: Life Science Leader

By Dan Schell, Editorial Director, Life Science Leader

In our May 2019 issue, we featured Synlogic as our “Company To Watch,” and we interviewed Dr. Aoife Brennan, who has been president and CEO since May 2018. When we caught up with her in February 2021, she explained that, internally, the company is still focused on developing its “Synthetic Biotic” medicines for metabolic diseases, but it is also investigating ways to expand into other areas such as oncology and inflammatory bowel disease. For this Q&A, we wanted to find out how the past year had affected the company, both operationally and from a clinical trial standpoint.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: